[The efficacy of amizon in the combined treatment of patients with epidemic parotitis].
Efficacy was studied of a new anti-inflammatory interferon-inducing drug preparation amizon in a combined therapy of epidemic parotiditis in 118 patients versus the group of comparison consisting of 147 patients. A positive effect was ascertained of the drug on clinical parameters, decrease in the incidence rate and in severity of complications (orchitis, pancreatitis), immune indices.
Frolov
A F
AF
Frolov
V M
VM
Loskutova
I V
IV
Danilenko
V F
VF
Bukhtiarova
T A
TA
Korobka
L N
LN
D000293:Adolescent; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000917:Antibody Formation / Q000187:drug effects; D015551:Autoimmunity / Q000187:drug effects; D000075202:Contraindications; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007369:Interferon Inducers / Q000627:therapeutic use*; D008297:Male; D009107:Mumps / Q000188:drug therapy* / Q000276:immunology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007369:Interferon Inducers